---
schema_version: "secwatch.filing_event.v1"
accession: "0001549084-23-000015"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2023-04-26T23:59:59+00:00"
generated_at: "2026-06-16T12:47:14.422883+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics director Stern resigns; CEO bonus potential raised to 75% of salary

## Summary
- Stanley Stern resigns from board effective April 26, 2023; no disagreement with Company.
- Stern's unvested RSUs under 2014 Equity Incentive Plan to fully vest on resignation.
- CEO Scott Davis's 2023 bonus potential increased from 50% to 75% of base salary.
- Board restated articles to remove Series A Preferred certificate of designations (no shares outstanding).
- Bylaws amended to address universal proxy rules and update meeting procedures.

## SEC filing metadata
- accession: 0001549084-23-000015
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2023-04-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000154908423000015/0001549084-23-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000154908423000015/ekso-20230420.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001549084-23-000015
- JSON: https://secwatch.observer/filing/0001549084-23-000015.json
- Plain text: https://secwatch.observer/filing/0001549084-23-000015.txt

## Key facts
- Executive change
  Stanley Stern resigned as director at EKSO BIONICS HOLDINGS, INC..
  - Action: resigned
  - Role: director
  source text: On April 25, 2023, Stanley Stern, a member of the board of directors (the “Board”) of Ekso Bionics Holdings, Inc. (the “Company”), notified the Company of his resignation from the Board, effective on April 26, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000154908423000015/0001549084-23-000015-index.htm
- Governance Changes
  EKSO BIONICS HOLDINGS, INC.: Amended and restated bylaws to address universal proxy rules and update provisions related to calling of stockholder and Board meetings (effective 2023-04-20).
  - Change: bylaw amendment
  - Effective: 2023-04-20
  source text: On April 20, 2023, the Board of the Company adopted amended and restated bylaws (the “Amended and Restated Bylaws”), which became effective immediately. Among other things, the Amended and Restated Bylaws address the universal proxy rules adopted by the U.S. Securities and Exchange Commission and update certain provisions related to the calling of stockholder and Board meetings.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000154908423000015/0001549084-23-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.